Evidence map›Paper›PMID 39915279›Full record

ArticleJournal of food science2025

Investigation of the quality, antimicrobial, and antioxidant effects of commercial carob molasses and determination of phenolic acids by using HPLC.

Didem Deliorman Orhan, Ergun Murat Sulak, Sultan Pekacar, Hasya Nazlı Gok, Burçin Ozüpek, Berrin Özçelik

Abstract read
In one paragraph

Article in Journal of food science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Didem Deliorman OrhanDepartment of Pharmacognosy, Faculty of Pharmacy, Gazi University, Ankara, Turkiye.ORCID https://orcid.org/0000-0003-3916-4048
Ergun Murat SulakDepartment of Pharmacognosy, Faculty of Pharmacy, Gazi University, Ankara, Turkiye.
Sultan PekacarDepartment of Pharmacognosy, Faculty of Pharmacy, Gazi University, Ankara, Turkiye.ORCID https://orcid.org/0000-0002-7782-9832
Hasya Nazlı GokDepartment of Pharmacognosy, Faculty of Pharmacy, Gazi University, Ankara, Turkiye.ORCID https://orcid.org/0000-0003-4115-7509
Burçin OzüpekDepartment of Pharmacognosy, Faculty of Pharmacy, Gazi University, Ankara, Turkiye.ORCID https://orcid.org/0000-0003-2159-9860
Berrin ÖzçelikDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy, Gazi University, Ankara, Turkiye.ORCID https://orcid.org/0000-0003-0525-1186

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study examines the bioactive properties and quality of commercial carob molasses, commonly consumed by children in Turkey for tonsillitis relief, while highlighting potential risks. Total phenolic content was analyzed spectrophotometrically, and phenolic acid composition by high-performance liquid chromatography (HPLC). For the determination of health benefits, antimicrobial and antioxidant activity methods were used, and for quality control, pH, 5-hydroxymethylfurfural (5-HMF), ash content, and water-soluble solids were determined. The results showed that there were differences in the bioactive properties of the samples. Sample 2 was found to have the highest antioxidant potential (93.86 ± 8.46 ascorbic acid equivalent [AAE]) and metal chelation ability (56.99 ± 1.91%). All carob molasses samples showed antimicrobial activity against Staphylococcus aureus, Enterococcus faecalis, Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, and Candida krusei, and minimum inhibitory concentration (MIC) values ranged from 200 to ≥400 µg/mL, approaching bactericidal/fungistatic effects. It was concluded that 5-HMF levels in all samples exceeded the 15 mg/kg limit and that many samples' pH values (between 4.71 and 5.18) and ash contents were outside the acceptable ranges. HPLC analysis showed that Sample 2 had the highest gallic acid content (569.423 ± 0.003 µg/100 mg), while Sample 6 had the highest cinnamic acid content (14.838 ± 0.003 µg/100 mg). As a result, it was observed that carob molasses, consumed with the thought that it was beneficial for tonsillitis, was not as effective as expected on the related microorganisms. It was concluded that better quality control in carob molasses production and storage is needed, and stricter food regulations should be implemented for public health. PRACTICAL APPLICATION: Carob is a fruit with important nutritional value for both adults and children thanks to its high sugar, dietary fiber, mineral, and phenolic compound content. The molasses obtained from the fruit is frequently used as a food supplement or to alleviate respiratory tract disorders in children. The findings of this study suggest that carob molasses, which is widely used for its health benefits, is not very effective against pathogens associated with respiratory tract disorders and underline the critical importance of improving quality criteria related to production, quality (5-hydroxymethylfurfural [5-HMF], pH levels, and ash content) control, and ensuring its safety after it is placed on the market. This is particularly important for the protection of vulnerable groups, including children, who may be more sensitive to potential risks. It is, therefore, essential that the quality of food products available on the market is rigorously assessed and that health claims are supported by scientific evidence.

Indexed as

Anti-Infective AgentsAntioxidantsHydroxybenzoatesMolassesCandida albicansChromatography, High Pressure LiquidEnterococcus faecalisGalactansHydrogen-Ion ConcentrationMannansMicrobial Sensitivity TestsPlant GumsPseudomonas aeruginosaQuality ControlStaphylococcus aureusAnti-Infective AgentsAntioxidantsGalactansHydroxybenzoateslocust bean gumMannansphenolic acidPlant GumsAntimicrobial activityAntioxidant activitycarob molassesHMFHPLC

Identifiers

PMID39915279
PMCPMC11802481

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.